Pentixapharm Holding AG (FRA:PTP) Buyback Yield %: -5.50 (As of Jun. 29, 2026)


FRA:PTP Pentixapharm Holding AG FRA:PTP
20 GF Score
Price €2.20
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG Buyback Yield %?

Pentixapharm Holding AG FRA:PTP -4.35% 20 Buyback Yield % is -5.50 as of Jun. 29, 2026. GuruFocus rates FRA:PTP with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 742 Biotechnology companies, Pentixapharm Holding AG ranks better than 57.95% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Pentixapharm Holding AG's current buyback yield was -5.50%.

Pentixapharm Holding AG Buyback Yield % Related Terms

Pentixapharm Holding AG Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Buyback Yield % Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 0.00 -26.99 0.00

Pentixapharm Holding AG Quarterly Data
Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -6.65

FRA:PTP vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Pentixapharm Holding AG's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pentixapharm Holding AG Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's Buyback Yield % falls into.


FRA:PTP
20GF Score
Pentixapharm Holding AG FRA:PTP
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Pentixapharm Holding AG's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 35.489256
=0.00%

Pentixapharm Holding AG's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 3) / 45.10506
=-6.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -5.50 mean?
Pentixapharm Holding AG (FRA:PTP) has a Buyback Yield % of -5.50 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pentixapharm Holding AG and its competitors. According to the industry distribution chart, Pentixapharm Holding AG ranks #312 out of 742 companies in the Biotechnology industry, placing it in the top 42%.
Is Pentixapharm Holding AG's Buyback Yield % too high?
Pentixapharm Holding AG's current Buyback Yield % is -5.50. Based on the distribution chart, Pentixapharm Holding AG ranks #312 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Pentixapharm Holding AG has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pentixapharm Holding AG ranks #312 out of 742 companies for Buyback Yield %. This puts Pentixapharm Holding AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Pentixapharm Holding AG and its competitors. Pentixapharm Holding AG's current Buyback Yield % is -5.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (FRA:PTP) has a current Buyback Yield % of -5.50. The current Buyback Yield % is -5.50. Pentixapharm Holding AG's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Pentixapharm Holding AG (FRA:PTP), the current Buyback Yield % is -5.50 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTP:GermanyPTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
20GF Score

Get the complete analysis for FRA:PTP

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.20
Price